Forian Inc. to Report Third Quarter 2025 Financial Results in November

Forian Inc. will announce its third quarter 2025 financial performance on November 14, 2025, providing critical insights into the data analytics company's growth trajectory across life sciences, healthcare and financial services sectors.

October 30, 2025
Forian Inc. to Report Third Quarter 2025 Financial Results in November

Forian Inc. (Nasdaq: FORA) will host a conference call and webcast at 4:30 p.m. ET on November 14, 2025 to discuss its third quarter 2025 financial results. The announcement comes as investors closely monitor the company's performance across its expanding portfolio of data science solutions serving multiple industries. The timing of this earnings release is particularly significant given Forian's strategic positioning in high-growth sectors including life sciences, healthcare and financial services.

The company's results will be reported in a press release prior to the call, providing stakeholders with comprehensive financial data and operational updates. Forian has established itself as a provider of data science driven information and analytics solutions, leveraging its industry leading expertise in acquiring, integrating, normalizing and commercializing large scale healthcare data assets. The third quarter results will offer valuable insights into how the company is executing its strategy following its recent acquisition of Kyber Data Science, which expanded its capabilities into the financial services industry.

Investors and analysts can access the conference call through registration, while the webcast will be available live at https://edge.media-server.com/mmc/p/dyiaxrbd. This earnings announcement represents a critical checkpoint for assessing Forian's progress in optimizing and measuring operational, clinical and financial performance for customers across traditional and emerging life sciences and healthcare payer and provider segments. The company's information products utilize sophisticated data management and data science capabilities built upon a comprehensive clinical data lake to identify unique relationships and generate proprietary insights.

The earnings release along with a replay of the call will be available promptly following its conclusion on the company's investor relations website at https://www.forian.com/investors. This quarterly reporting cycle provides market participants with essential data points to evaluate Forian's competitive positioning and growth trajectory in the rapidly evolving data analytics landscape. The company's performance metrics will be closely scrutinized given the forward-looking nature of its business operations and the inherent uncertainties in technology-driven markets.